Results 161 to 170 of about 23,408 (219)

In-vitro studies of phytochemical, Antioxidant, Antibacterial and Enzymatic inhibition of Oxalis corniculata whole plant from South Waziristan Tribal District Pakistan. [PDF]

PLoS One
Ullah I, Shad Bibi N, Sadiq A, Niazy B, Hesam AM.   +4 more
europepmc   +1 more source

Modulation of monoaminergic neurotransmission in substance use disorders: a neuropharmacological perspective focusing on plant-derived metabolites. [PDF]

Front Pharmacol
Sivamaruthi BS, Kesika P, Chaiyasut C, Ragu Varman D.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Switching Monoamine Oxidase Inhibitors

Drug Intelligence & Clinical Pharmacy, 1985
Substituting one monoamine oxidase inhibitor for another is recommended only after a drug-free interval to avoid hypertensive emergencies. The evidence and mechanism firmly supporting this caution is lacking. We report a case where monoamine oxidase inhibitors were substituted without apparent adverse consequences.
B L, True, B, Alexander, B, Carter
openaire   +2 more sources

Metabolism of monoamine oxidase inhibitors

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1989
1. Despite the fact that monoamine oxidase inhibitors have been used clinically and in animal experiments for many years, much still remains unknown about their metabolism. An overview of the metabolic aspects of several monoamine oxidase inhibitors, including phenelzine, tranylcypromine, pheniprazine, pargyline and deprenyl, is presented. 2.
G B, Baker, R T, Coutts
openaire   +2 more sources